Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX
Earnings Data
Report Date
Mar 04, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.09Last Year’s EPS
0.22Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment with strong clinical progress and strategic advancements in key programs, despite a decrease in revenue and some adverse events in trials.Company Guidance
Strong Clinical Progress for CX-2051
Phase I study of CX-2051 showed promising results with a 28% response rate, significantly higher than current standard of care. Preliminary median progression-free survival reached 5.8 months, compared to 2-3 months for existing treatments.
Increased Enrollment and Expansion in Trials
Enrollment for CX-2051's Phase I study has significantly increased, reaching approximately 100 patients, which provides a robust data set for analysis.
Financial Stability and Efficient Capital Allocation
The company ended the quarter with $143.6 million in cash and investments, ensuring operations are funded until at least the second quarter of 2027.
New Strategic Appointment
Rachael Lester joined as Chief Business Officer, bringing valuable strategic planning and business development experience.
Progress in CX-801 Program
CX-801, in combination with KEYTRUDA, is showing positive initial biomarker data in advanced melanoma, indicating robust interferon signaling and immune activation.
CTMX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CTMX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $4.19 | $3.62 | -13.60% |
Aug 07, 2025 | $2.10 | $2.35 | +11.90% |
May 12, 2025 | $0.93 | $2.13 | +129.03% |
Mar 06, 2025 | $0.62 | $0.66 | +6.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CytomX Therapeutics Inc (CTMX) report earnings?
CytomX Therapeutics Inc (CTMX) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
What is CytomX Therapeutics Inc (CTMX) earnings time?
CytomX Therapeutics Inc (CTMX) earnings time is at Mar 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CTMX EPS forecast?
CTMX EPS forecast for the fiscal quarter 2025 (Q4) is -0.09.